Roelof Rongen

Overview

Roelof Rongen received an average of $694K in total compensation, including $242K in salary, at Matinas BioPharma Holdings from 2014 to 2019.

Related executives

We found nine more executives who work or worked at Matinas BioPharma Holdings.

Jerome Jabbour

Matinas BioPharma Holdings

Chief Executive Officer

James Ferguson

Matinas BioPharma Holdings

Chief Medical Officer

Theresa Matkovits

Matinas BioPharma Holdings

Chief Development Officer

Keith Kucinski

Matinas BioPharma Holdings

Chief Financial Officer

Raphael Mannino

Matinas BioPharma Holdings

Chief Scientific Officer

Gary Gaglione

Matinas BioPharma Holdings

Chief Financial Officer

Dominick DiPaolo

Matinas BioPharma Holdings

Former Senior Vice President, Quality and Regulatory Compliance

Douglas Kling

Matinas BioPharma Holdings

Senior Vice President, Clinical Development & Project Management

News

You may also like